Tag: CADTH

Zeal Tips

The Drug Approval Process

In this short webinar, James Radke provides an overview of the drug approval process in Canada: Health Canada, CADTH, PMPRB, INESSS, pCPA, and the proposed National Pharmacare program.

Read More

Health Canada to Review ALS Drug (edaravone)

Health Canada has accepted Mitsubishi Tanabe Pharma Corporation’s New Drug Submission (NDS) for edaravone to treat patients with amyotrophic lateral sclerosis (ALS). Health Canada has also granted the drug a Priority Review so that it should take less than 6 months for the review process to be completed.

Read More

The Drug Review Process in Canada

Anyone who has participated in the Canadian healthcare system understands that it is complicated. And like many endeavours, the more government agencies involved, the more complicated (and convoluted) it seems to get. The same is true for the approval and disbursement of new medicines.

Read More
Loading